CUDC-907 mesylate

SKU: orb1738721

Description

CUDC-907 mesylate is a dual inhibitor of HDAC and PI3K developed by Curis. It is being clinically evaluated for various relapsed or refractory cancers, including lymphomas and solid tumors. Preclinical studies demonstrate its activity in inducing apoptosis and inhibiting tumor growth in both cellular and animal models.

Research Area

Cell Biology, Epigenetics & Chromatin, Molecular Biology, Signal Transduction

Images & Validation

−

Key Properties

−

CAS Number	1401998-36-4
MW	604.66
Formula	C₂₄H₂₈N₈O₇S₂
SMILES	CS(O)(=O)=O.COc1ccc(cn1)-c1nc(N2CCOCC2)c2sc(CN(C)c3ncc(cn3)C(=O)NO)cc2n1
Target	Others,HDAC,PI3K,Apoptosis

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Compound Identifiers

PubChem CID

88962004 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols